logoPROFESSIONAL VERSION

Neurological Paraneoplastic Syndromes in Small Animals

ByBrooke Britton, DVM DACVIM (Oncology), Schwarzman Animal Medical Center
Reviewed ByPatrick Carney, DVM, PhD, DACVIM, Cornell University College of Veterinary Medicine
Reviewed/Revised Modified Sept 2025
v103249473

Myasthenia Gravis in Small Animals

Myasthenia gravis is an immune-mediated paraneoplastic syndrome, resulting from antibody production against nicotinic acetylcholine (ACh) receptors within the neuromuscular junction, that occurs most commonly in dogs and cats with thymoma (see image) (1). 

Other tumors reported to cause this syndrome include osteosarcoma, oral sarcomas, cholangiocellular carcinoma, and nonepitheliotropic lymphoma. Generalized myasthenia gravis is usually associated with exercise-induced muscular weakness, with concurrent weakness of the muscles of the esophagus, face, and pharynx/larynx.

Definitive diagnosis of myasthenia gravis is based on testing for circulating antibodies against the ACh receptor. A positive neostigmine test also supports the diagnosis.

Surgical removal of thymoma or the underlying tumor is recommended; however, postoperative improvement is inconsistent. Anticholinesterase therapy with pyridostigmine bromide and immunosuppressive therapy are recommended before surgery, when possible, to decrease the risk of perioperative aspiration pneumonia (1). 

Morbidity and mortality rates are substantial in patients with megaesophagus secondary to myasthenia gravis, even if the underlying tumor is removed.

For More Information

References

  1. Robat CS, Cesario L, Gaeta R, et al. Clinical features, treatment options, and outcome in dogs with thymoma: 116 cases (1999–2010)J Vet Med Assoc. 2013;243(10):1448-1454. doi:10.2460/javma.243.10.1448

quizzes_lightbulb_red
Test your Knowledge nowTake a Quiz!
iOS ANDROID
iOS ANDROID
iOS ANDROID